Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression.
B B Kahn, … , S W Cushman, L Rossetti
B B Kahn, … , S W Cushman, L Rossetti
Published February 1, 1991
Citation Information: J Clin Invest. 1991;87(2):561-570. https://doi.org/10.1172/JCI115031.
View: Text | PDF
Research Article Article has an altmetric score of 9

Normalization of blood glucose in diabetic rats with phlorizin treatment reverses insulin-resistant glucose transport in adipose cells without restoring glucose transporter gene expression.

  • Text
  • PDF
Abstract

Evidence is emerging for a direct role of glucose, independent of changes in insulin, in the regulation of cellular glucose transport and glucose utilization in vivo. In this study we investigate potential cellular and molecular mechanisms for this regulatory effect of glucose by determining how normalization of glycemia without insulin therapy in diabetic rats influences 3-O-methylglucose transport and the expression and translocation of two genetically distinct species of glucose transporters (GTs) in adipose cells. These results are compared with alterations in glucose disposal in vivo measured by euglycemic clamp. In rats rendered diabetic by 90% pancreatectomy, insulin-stimulated glucose transport in adipose cells is decreased 50% in parallel with reduced insulin-mediated glucose disposal in vivo. Levels of adipose/muscle GTs measured by immunoblotting are decreased in adipose cell subcellular membrane fractions, as are the corresponding mRNA levels assessed by Northern blotting of total adipose cell RNA. Normalization of blood glucose in diabetic rats with phlorizin, which impairs renal tubular glucose reabsorption and thus enhances glucose excretion, restores insulin-stimulated glucose transport in adipose cells and insulin-mediated glucose disposal in vivo. Importantly, levels of the adipose/muscle GT protein remain 43% reduced in the low-density microsomes in the basal state and 46% reduced in the plasma membranes in the insulin-stimulated state. Adipose/muscle GT mRNA levels remain approximately 50% depressed. Levels of the HepG2/brain GT protein and mRNA are unaltered by diabetes or phlorizin treatment. Thus, changes in ambient glucose independent of changes in ambient insulin can regulate the glucose transport response to insulin in isolated adipose cells and changes in responsiveness parallel alterations in glucose uptake in vivo. Since this effect can occur without alteration in the expression of the two species of glucose transporters present in adipose cells or in their translocation to the plasma membrane in response to insulin, it may result from changes in GT functional activity.

Authors

B B Kahn, G I Shulman, R A DeFronzo, S W Cushman, L Rossetti

×

Total citations by year

Year: 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2006 2005 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 Total
Citations: 1 1 1 2 2 3 1 1 6 3 6 5 5 9 4 6 4 2 1 3 2 6 3 5 6 2 3 3 11 8 6 5 126
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (126)

Title and authors Publication Year
SGLT2 inhibitors: Cardio-renal metabolic drugs for the ages
Ralph A. DeFronzo
Journal of Clinical Investigation 2024
Nephroprotective Properties of Antidiabetic Drugs.
Gerdes C, Müller N, Wolf G, Busch M
Journal of Clinical Medicine 2023
Impact of Sodium–Glucose Cotransporter 2 (SGLT2) Inhibitors on Arterial Stiffness and Vascular Aging—What Do We Know So Far? (A Narrative Review)
Adam CA, Anghel R, Marcu DT, Mitu O, Roca M, Mitu F
Life Sciences 2022
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review
V Mollace, GM Rosano, SD Anker, AJ Coats, P Seferovic, R Mollace, A Tavernese, M Gliozzi, V Musolino, C Carresi, J Maiuolo, R Macrì, F Bosco, M Chiocchi, F Romeo, M Metra, M Volterrani
Nutrients 2021
Sodium-Glucose Cotransporter 2 Inhibitors Mechanisms of Action: A Review
J Fonseca-Correa, R Correa-Rotter
Frontiers in Medicine 2021
Diet intake control is indispensable for the gluconeogenic response to sodium–glucose cotransporter 2 inhibition in male mice
E Hashiuchi, H Watanabe, K Kimura, M Matsumoto, H Inoue, Y Inaba
Journal of Diabetes Investigation 2020
The expanding role of SGLT2 inhibitors beyond glucose-lowering to cardiorenal protection
E Brown, JP Wilding, U Alam, TM Barber, J Karalliedde, DJ Cuthbertson
Annals of Medicine 2020
Biliopancreatic Diversion Induces Greater Metabolic Improvement Than Roux-en-Y Gastric Bypass
LA Harris, BD Kayser, C Cefalo, L Marini, JD Watrous, J Ding, M Jain, JG McDonald, BM Thompson, E Fabbrini, JC Eagon, BW Patterson, B Mittendorfer, G Mingrone, S Klein
Cell Metabolism 2019
Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic Disease
T Schumann, J König, C Henke, DM Willmes, SR Bornstein, J Jordan, MF Fromm, AL Birkenfeld, MC Michel
Pharmacological reviews 2019
Sodium–Glucose Cotransporter 2 Inhibitors: A Case Study in Translational Research
AL Beitelshees, BR Leslie, SI Taylor
Diabetes 2019
Effect of Chronic Hyperglycemia on Glucose Metabolism in Subjects with Normal Glucose Tolerance
C Shannon, A Merovci, J Xiong, D Tripathy, F Lorenzo, D McClain, M Abdul-Ghani, L Norton, RA DeFronzo
Diabetes 2018
Astragalus polysaccharides attenuates TNF-α-induced insulin resistance via suppression of miR-721 and activation of PPAR-γ and PI3K/AKT in 3T3-L1 adipocytes
Bin Ke, Xiao Ke, Xuesi Wan, Yubin Yang, Yingjuan Huang, Jian Qin, Chengheng Hu, Lin Shi
American journal of translational research 2017
Renal, metabolic and cardiovascular considerations of SGLT2 inhibition
RA DeFronzo, L Norton, M Abdul-Ghani
Nature Reviews Nephrology 2016
The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet
JH Han, TJ Oh, G Lee, HJ Maeng, DH Lee, KM Kim, SH Choi, HC Jang, HS Lee, KS Park, YB Kim, S Lim
Diabetologia 2016
The SGLT2 inhibitor empagliflozin improves insulin sensitivity in db/db mice both as monotherapy and in combination with linagliptin
M Kern, N Klöting, M Mark, E Mayoux, T Klein, M Blüher
Metabolism 2016
Insulin Sensitivity-Enhancing Activity of Phlorizin is Associated with Lipopolysaccharides decrease and Gut Microbiota Changes in obese and type 2 diabetes (db/db) Mice
X Mei, X Zhang, Z Wang, Z Gao, G Liu, H Hu, L Zou, X Li
Journal of Agricultural and Food Chemistry 2016
Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice
K Ogura, M Ogura, T Shoji, Y Sato, Y Tahara, G Yamano, H Sato, K Sugizaki, N Fujita, H Tatsuoka, R Usui, E Mukai, S Fujimoto, N Inagaki, K Nagashima
Journal of Agricultural and Food Chemistry 2016
SGLT-2 inhibitors: Their pleiotropic properties
NG Vallianou, E Geladari, CE Kazazis
Diabetes and Metabolic Syndrome: Clinical Research and Reviews 2016
Hypothalamic Neurones Governing Glucose Homeostasis
R Coppari
Journal of Neuroendocrinology 2015
Renal Sodium-Glucose Cotransporter Inhibition in the Management of Type 2 Diabetes Mellitus
MA Abdul-Ghani, L Norton, RA DeFronzo
American journal of physiology. Renal physiology 2015
Clinical Pharmacokinetic, Pharmacodynamic, and Drug–Drug Interaction Profile of Canagliflozin, a Sodium-Glucose Co-transporter 2 Inhibitor
D Devineni, D Polidori
Clinical Pharmacokinetics 2015
Comprehensive Physiology
SN Cheuvront, RW Kenefick
Comprehensive Physiology 2014
Effects of sodium-glucose cotransporter 2 selective inhibitor ipragliflozin on hyperglycaemia, oxidative stress, inflammation and liver injury in streptozotocin-induced type 1 diabetic rats: Ipragliflozin for type 1 diabetes
A Tahara, E Kurosaki, M Yokono, D Yamajuku, R Kihara, Y Hayashizaki, T Takasu, M Imamura, Q Li, H Tomiyama, Y Kobayashi, A Noda, M Sasamata, M Shibasaki
Journal of Pharmacy and Pharmacology 2014
Using nonrandom two-liquid model for solvent system selection in counter-current chromatography
DB Ren, YH Qin, YH Yun, HM Lu, XQ Chen, YZ Liang
Journal of Chromatography A 2014
Pathobiology of Human Disease
S Akilesh
Pathobiology of Human Disease 2014
Metabolic effects of SGLT-2 inhibitors beyond increased glucosuria: A review of the clinical evidence
AJ Scheen, N Paquot
Diabetes & Metabolism 2014
Lowering plasma glucose concentration by inhibiting renal sodium-glucose cotransport
MA Abdul-Ghani, RA DeFronzo
Journal of Internal Medicine 2014
Protein O-GlcNAcylation in diabetes and diabetic complications
J Ma, GW Hart
Expert Review of Proteomics 2013
SGLT2 Inhibition: A Novel Prospective Strategy in Treatment of Diabetes Mellitus
AB Deshmukh, MC Patel, B Mishra
Renal Failure 2013
Ipragliflozin and other sodium–glucose cotransporter-2 (SGLT2) inhibitors in the treatment of type 2 diabetes: Preclinical and clinical data
E Kurosaki, H Ogasawara
Pharmacology & Therapeutics 2013
The Role of the Kidney in Hyperglycemia: A New Therapeutic Target in Type 2 Diabetes Mellitus
D Hinnen
The Journal of cardiovascular nursing 2013
Sodium-glucose cotransporter inhibition: therapeutic potential for the treatment of type 2 diabetes mellitus: SGLT2 Inhibitors in the Treatment of Type 2 Diabetes
P Raskin
Diabetes/Metabolism Research and Reviews 2013
Efficacy and Safety of SGLT2 Inhibitors in the Treatment of Type 2 Diabetes Mellitus
MA Abdul-Ghani, L Norton, RA DeFronzo
Current Diabetes Reports 2012
SGLT2 inhibitors: a promising new therapeutic option for treatment of type 2 diabetes mellitus: SGLT2 inhibitors in diabetes
M Misra
Journal of Pharmacy and Pharmacology 2012
Antidiabetic Effects of SGLT2-Selective Inhibitor Ipragliflozin in Streptozotocin^|^ndash;Nicotinamide-Induced Mildly Diabetic Mice
A Tahara, E Kurosaki, M Yokono, D Yamajuku, R Kihara, Y Hayashizaki, T Takasu, M Imamura, L Qun, H Tomiyama, Y Kobayashi, A Noda, M Sasamata, M Shibasaki
Journal of Pharmacological Sciences 2012
Animal Models in Diabetes Research
HG Joost, H Al-Hasani, A Schürmann
2012
Tofogliflozin, a Potent and Highly Specific Sodium/Glucose Cotransporter 2 Inhibitor, Improves Glycemic Control in Diabetic Rats and Mice
M Suzuki, K Honda, M Fukazawa, K Ozawa, H Hagita, T Kawai, M Takeda, T Yata, M Kawai, T Fukuzawa, T Kobayashi, T Sato, Y Kawabe, S Ikeda
The Journal of pharmacology and experimental therapeutics 2012
Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans
JF List, JM Whaley
Kidney International 2011
Remogliflozin etabonate, a selective inhibitor of the sodium-dependent transporter 2 reduces serum glucose in type 2 diabetes mellitus patients
RL Dobbins, R O’Connor-Semmes, A Kapur, C Kapitza, G Golor, I Mikoshiba, W Tao, EK Hussey
Diabetes Obesity and Metabolism 2011
Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with Type 2 diabetes mellitus
JE Gerich, A Bastien
Expert Review of Clinical Pharmacology 2011
Reduction in Reactive Oxygen Species Production by Mitochondria From Elderly Subjects With Normal and Impaired Glucose Tolerance
S Ghosh, R Lertwattanarak, N Lefort, M Molina-Carrion, J Joya-Galeana, BP Bowen, JJ Garduno-Garcia, M Abdul-Ghani, A Richardson, RA DeFronzo, L Mandarino, HV Remmen, N Musi
Diabetes 2011
A New Approach to Glucose Control in Type 2 Diabetes: The Role of Kidney Sodium-Glucose Co-transporter 2 Inhibition
J Basile
Postgraduate Medicine 2011
Role of Sodium-Glucose Cotransporter 2 (SGLT 2) Inhibitors in the Treatment of Type 2 Diabetes
MA Abdul-Ghani, L Norton, RA DeFronzo
Endocrine reviews 2011
In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes
KH Chun, KD Choi, DH Lee, YS Jung, RR Henry, TP Ciaraldi, YB Kim
American journal of physiology. Endocrinology and metabolism 2011
Management of Pediatric Obesity and Diabetes
RJ Ferry
2011
Dapagliflozin for adults with type 2 diabetes mellitus
Raval AD, Chovatiya K, Bhavsar AB, Patel MH
The Cochrane Database of Systematic Reviews 2011
Rapid Upregulation of Sodium-Glucose Transporter SGLT1 in Response to Intestinal Sweet Taste Stimulation
AT Stearns, A Balakrishnan, DB Rhoads, A Tavakkolizadeh
Annals of Surgery 2010
Renal glucose transporters: novel targets for hyperglycemia management
A Mather, C Pollock
Nature Reviews Nephrology 2010
Enhancement of Organ Regeneration in Animal Models by a Stem Cell-Stimulating Plant Mixture
I Kiss, A Tibold, R Halmosi, É Bartha, K Koltai, Z Orsós, L Bujdosó, I Ember
Journal of Medicinal Food 2010
In vivo activation of ROCK1 by insulin is impaired in skeletal muscle of humans with type 2 diabetes
KH Chun, KD Choi, DH Lee, Y Jung, RR Henry, TP Ciaraldi, YB Kim
American journal of physiology. Endocrinology and metabolism 2010
Insulin is a stronger inducer of insulin resistance than hyperglycemia in mice with type 1 diabetes mellitus (T1DM)
HY Liu, SY Cao, T Hong, J Han, Z Liu, W Cao
The Journal of biological chemistry 2009
Glucose toxicity: The leading actor in the pathogenesis and clinical history of type 2 diabetes – mechanisms and potentials for treatment
A Giaccari, G Sorice, G Muscogiuri
Nutrition, Metabolism and Cardiovascular Diseases 2009
From victim to ally: the kidney as an emerging target for the treatment of diabetes mellitus
H Bays
Current Medical Research and Opinion 2009
Long-term treatment with sergliflozin etabonate improves disturbed glucose metabolism in KK-Ay mice
K Katsuno, Y Fujimori, Y Ishikawa-Takemura, M Isaji
European Journal of Pharmacology 2009
Inhibitors of type 2 sodium glucose co-transporters – a new strategy for diabetes treatment
A Bołdys, B Okopień
Pharmacological Reports 2009
Impact of Roux-en-Y gastric bypass surgery on rat intestinal glucose transport
AT Stearns, A Balakrishnan, A Tavakkolizadeh
AJP Gastrointestinal and Liver Physiology 2009
Dapagliflozin, a Selective SGLT2 Inhibitor, Improves Glucose Homeostasis in Normal and Diabetic Rats
S Han, DL Hagan, JR Taylor, L Xin, W Meng, SA Biller, JR Wetterau, WN Washburn, JM Whaley
2008
Series in Medical Physics and Biomedical Engineering: Physiological Norm and Pathology
T Denisova, L Malinova
Stem Cell Labeling for Delivery and Tracking Using Noninvasive Imaging 2008
Inhibition of Renal Glucose Reabsorption: A Novel Strategy for Achieving Glucose Control in Type 2 Diabetes Mellitus
MA Abdul-Ghani, RA DeFronzo
Endocrine Practice 2008
Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
JF List, V Woo, E Morales, W Tang, FT Fiedorek
2008
Glucose Toxicity Is Responsible for the Development of Impaired Regulation of Endogenous Glucose Production and Hepatic Glucokinase in Zucker Diabetic Fatty Rats
Y Fujimoto, TP Torres, EP Donahue, M Shiota
2006
Targeting glycogen synthase kinase-3 in insulin signalling
S Frame, D Zheleva
Expert Opinion on Therapeutic Targets 2006
Phlorizin: a review
JR Ehrenkranz, NG Lewis, CR Kahn, J Roth
Diabetes/Metabolism Research and Reviews 2005
International Textbook of Diabetes Mellitus
RA DeFronzo, L Mandarino, E Ferrannini
International Textbook of Diabetes Mellitus 2003
N -acetylcysteine and taurine prevent hyperglycemia-induced insulin resistance in vivo: possible role of oxidative stress
CA Haber, TK Lam, Z Yu, N Gupta, T Goh, E Bogdanovic, A Giacca, IG Fantus
American journal of physiology. Endocrinology and metabolism 2003
Impaired glucose tolerance: do pharmacological therapies correct the underlying metabolic disturbance?
RA Defronzo
The British Journal of Diabetes & Vascular Disease 2003
Insulin Resistance and Insulin Resistance Syndrome
A Cincotta
Insulin Resistance and Insulin Resistance Syndrome 2002
Mice Deficient in the Insulin-regulated Membrane Aminopeptidase Show Substantial Decreases in Glucose Transporter GLUT4 Levels but Maintain Normal Glucose Homeostasis
SR Keller, AC Davis, KB Clairmont
The Journal of biological chemistry 2002
Regulation of IRS-2 tyrosine phosphorylation in fasting and diabetes
FA Rojas, AE Hirata, MJ Saad
Molecular and Cellular Endocrinology 2001
Nuevos tratamientos en la diabetes mellitus
EF Nogueras
Endocrinología y Nutrición 2001
Insulin can enhance GLUT4 gene expression in 3T3-F442A cells and this effect is mimicked by vanadate but counteracted by cAMP and high glucose--potential implications for insulin resistance
Z W Yu, J Burén, S Enerbäck, E Nilsson, L Samuelsson, J W Eriksson
Biochimica et Biophysica Acta 2001
Effects of cellular ATP depletion on glucose transport and insulin signaling in 3T3-L1 adipocytes
J Kang, E Heart, CK Sung
American journal of physiology. Endocrinology and metabolism 2001
Inhibitory effect of hyperglycemia on insulin-induced Akt/protein kinase B activation in skeletal muscle
A Oku, M Nawano, K Ueta, T Fujita, I Umebayashi, K Arakawa, T Kano-Ishihara, A Saito, M Anai, M Funaki, M Kikuchi, Y Oka, T Asano
American journal of physiology. Endocrinology and metabolism 2001
Physiological hyperinsulinemia impairs insulin-stimulated glycogen synthase activity and glycogen synthesis
P Iozzo, T Pratipanawatr, H Pijl, C Vogt, V Kumar, R Pipek, M Matsuda, LJ Mandarino, KJ Cusi, RA DeFronzo
American journal of physiology. Endocrinology and metabolism 2001
Mechanisms of vanadium action: insulin-mimetic or insulin-enhancing agent?
MC Cam, RW Brownsey, JH McNeill
Canadian Journal of Physiology and Pharmacology 2000
Innovation im Pflanzenschutz: Trends in der Forschung
J Stetter, F Lieb
Angewandte Chemie 2000
Glucosamine-induced insulin resistance in 3T3-L1 adipocytes
E Heart, WS Choi, CK Sung
American journal of physiology. Endocrinology and metabolism 2000
Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle
L Rossetti, AE Stenbit, W Chen, M Hu, N Barzilai, EB Katz, MJ Charron
Journal of Clinical Investigation 1999
Prevention of insulin resistance and diabetes in mice heterozygous for GLUT4 ablation by transgenic complementation of GLUT4 in skeletal muscle
L Rossetti, AE Stenbit, W Chen, M Hu, N Barzilai, EB Katz, MJ Charron
Diabetes 1999
Localization and quantification of glucose transporters in liver of growth-retarded fetal and neonatal rats
RH Lane, SE Crawford, AS Flozak, RA Simmons
American journal of physiology. Endocrinology and metabolism 1999
Glucosamine Regulation of Glucose Metabolism in Cultured Human Skeletal Muscle Cells: Divergent Effects on Glucose Transport/Phosphorylation and Glycogen Synthase in Non-Diabetic and Type 2 Diabetic Subjects1
TP Ciaraldi, L Carter, S Nikoulina, S Mudaliar, DA McClain, RR Henry
Endocrinology 1999
Glucose Rapidly Decreases Plasma Membrane GLUT4 Content in Rat Skeletal Muscle
A Marette, D Dimitrakoudis, Q Shi, CD Rodgers, A Klip, M Vranic
Endocrine 1999
Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat
BB Kahn
Journal of Clinical Investigation 1998
Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat
BB Kahn
Metabolism 1998
Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat
BB Kahn
Metabolism 1998
Mechanisms of Insulin-Resistant Glucose Utilization in Rat Skeletal Muscle
NM Rizk, DA Meier, GR Krakower, AH Kissebah
Molecular Genetics and Metabolism 1998
Skeletal Muscle Metabolism in Exercise and Diabetes
EA Richter, B Kiens, H Galbo, B Saltin
1998
Clinical islet cell transplantation: Are we there yet?
L Rosenberg
International Journal of Gastrointestinal Cancer 1998
Glucose transporter levels in a male spontaneous non-insulin-dependent diabetes mellitus rat of the Otsuka Long–Evans Tokushima Fatty strain
K Toide
Diabetes Research and Clinical Practice 1997
Insulin resistance in non-obese, non—insulin-dependent diabetic patients with diabetic nephropathy
M Emoto, Y Nishizawa, K Maekawa, T Kawagishi, K Kogawa, Y Hiura, K Mori, S Tanaka, E Ishimura, M Inaba, Y Okuno, H Morii
Metabolism 1997
Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis
RV Considine, MR Nyce, LE Allen, LM Morales, S Triester, J Serrano, J Colberg, S Lanza-Jacoby, JF Caro
Journal of Clinical Investigation 1996
Chronic activation of protein kinase C in soleus muscles and other tissues of insulin-resistant type II diabetic Goto-Kakizaki (GK), obese/aged, and obese/Zucker rats. A mechanism for inhibiting glycogen synthesis
RV Considine, MR Nyce, LE Allen, LM Morales, S Triester, J Serrano, J Colberg, S Lanza-Jacoby, JF Caro
Journal of Endocrinology 1996
In vivo effects of dexamethasone and sucrose on glucose transport (GLUT-4) protein tissue distribution
L Coderre, GA Vallega, PF Pilch, SR Chipkin
American journal of physiology. Endocrinology and metabolism 1996
In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats
L Rossetti, M Hawkins, W Chen, J Gindi, N Barzilai
Journal of Clinical Investigation 1995
Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity
AD Baron, JS Zhu, JH Zhu, H Weldon, L Maianu, WT Garvey
Journal of Clinical Investigation 1995
Palmitoylation of the glucose transporter in blood-brain barrier capillaries
J F Pouliot, R Béliveau
Biochimica et Biophysica Acta 1995
Facilitative glucose transporters
M MUECKLER
European Journal of Biochemistry 1994
Subcellular localization and trafficking of the GLUT4 glucose transporter isoform in insulin-responsive cells
GD Holman, SW Cushman
BioEssays 1994
Pancreas and islet transplantation: An update
DE Sutherland, RW Gruessner, PF Gores
Transplantation Reviews 1994
Diabetes can be prevented by reducing insulin production
JE Sprietsma, GE Schuitemaker
Medical Hypotheses 1994
Impaired glucose transport in skeletal muscle but normal GLUT-4 tissue distribution in glucose-infused rats
MB Davidson, C Bouch, N Venkatesan, RG Karjala
American journal of physiology. Endocrinology and metabolism 1994
Persistence of disturbed adipocyte metabolism in sterptozocin-induced diabetic rats despite near-euglycemia with phlorizin
GJ Mick, K Hingre, M Benedict, KL McCormick
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1994
Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man
SD Prato, F Leonetti, DC Simonson, P Sheehan, M Matsuda, RA DeFronzo
Diabetologia 1994
Effects of glycaemia on glucose transport in isolated skeletal muscle from patients with NIDDM: in vitro reversal of muscular insulin resistance
JR Zierath, D Galuska, LA Nolte, A Thrne, JS Kristensen, H Wallberg-Henriksson
Diabetologia 1994
The feto-placental glucose steal phenomenon is a major cause of maternal metabolic adaptation during late pregnancy in the rat
CJ Nolan, J Proietto
Diabetologia 1994
EJB Reviews 1994
P Christen, E Hofmann
1994
Enhanced peripheral glucose utilization in transgenic mice expressing the human GLUT4 gene
JL Treadway, DM Hargrove, NA Nardone, RK McPherson, JF Russo, AJ Milici, HA Stukenbrok, EM Gibbs, RW Stevenson, JE Pessin
The Journal of biological chemistry 1994
The Effect of Intensive Insulin Therapy on the Insulin-regulatable Glucose Transporter (GLUT4) Expression in Skeletal Muscle in Type 1 Diabetes
PH Andersen, H Vestergaard, S Lund, P Vedel, S Junker, BB Kahn, O Pedersen
Diabetic Medicine 1993
Transgenic mice expressing the human GLUT4/muscle-fat facilitative glucose transporter protein exhibit efficient glycemic control
ML Liu, EM Gibbs, SC McCoid, AJ Milici, HA Stukenbrok, RK McPherson, JL Treadway, JE Pessin
Proceedings of the National Academy of Sciences 1993
Mammalian passive glucose transporters: members of an ubiquitous family of active and passive transport proteins
SA Baldwin
Biochimica et Biophysica Acta (BBA) - Reviews on Biomembranes 1993
1 Cellular insulin action and insulin resistance
WT Garvey, MJ Birnbaum
Baillière's Clinical Endocrinology and Metabolism 1993
Insulin resistance in polycystic ovary syndrome: decreased expression of GLUT-4 glucose transporters in adipocytes
D Rosenbaum, RS Haber, A Dunaif
American journal of physiology. Endocrinology and metabolism 1993
Phlorizin treatment of diabetic rats partially reverses the abnormal expression of genes involved in hepatic glucose metabolism
SM Brichard, JC Henquin, J Girard
Diabetologia 1993
Regulation of the GLUT4/muscle-fat glucose transporter mRNA in adipose tissue of insulin-deficient diabetic rats
PM Gerrits, AL Olson, JE Pessin
The Journal of biological chemistry 1993
Use of bismannose photolabel to elucidate insulin-regulated GLUT4 subcellular trafficking kinetics in rat adipose cells. Evidence that exocytosis is a critical site of hormone action
S Satoh, H Nishimura, AE Clark, IJ Kozka, SJ Vannucci, IA Simpson, MJ Quon, SW Cushman, GD Holman
The Journal of biological chemistry 1993
Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors
ER Seaquist, RP Robertson
Journal of Clinical Investigation 1992
Effect of streptozotocin-induced diabetes on GLUT-4 phosphorylation in rat adipocytes
N Begum, B Draznin
Journal of Clinical Investigation 1992
Treatment of diabetes mellitus
RP Robertson, DJ Klein
Diabetologia 1992
Alterations in glucose transporter expression and function in diabetes: Mechanisms for insulin resistance
BB Kahn
Journal of Cellular Biochemistry 1992
Acute and chronic signals controlling glucose transport in skeletal muscle
A Klip, A Marette
Journal of Cellular Biochemistry 1992
Insulin resistance in Type 2 (non-insulin-dependent) diabetic patients and their relatives is not associated with a defect in the expression of the insulin-responsive glucose transporter (GLUT-4) gene in human skeletal muscle
J Eriksson, L Koranyi, R Bourey, C Schalin-Jntti, E Widn, M Mueckler, AM Permutt, LC Groop
Diabetologia 1992
Decreased in vivo glucose uptake but normal expression of GLUT1 and GLUT4 in skeletal muscle of diabetic rats
BB Kahn, L Rossetti, HF Lodish, MJ Charron
Journal of Clinical Investigation 1991
Insulin Resistance — Mechanisms, Syndromes, and Implications
FH Epstein, DE Moller, JS Flier
New England Journal of Medicine 1991
International Review of Cytology
RA Miller
International Review of Cytology 1991
Proceedings of the 1990 Laurentian Hormone Conference
AE Boyd, L Aguilar-Bryan, J Bryan, DL Kunze, L Moss, DA Nelson, AS Rajan, H Raef, H Xiang, GC Yaney
Proceedings of the 1990 Laurentian Hormone Conference 1991
Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha
JM Stephens, PH Pekala
The Journal of biological chemistry 1991

← Previous 1 2 3 4 5 6 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 27 patents
54 readers on Mendeley
See more details